Productivity losses associated with cardiovascular disease: a systematic review.
People with cardiovascular disease (CVD) often require time off work to recover from illness or surgery; for example, following a myocardial infarction (MI) or stroke. These individuals incur income losses, work-related productivity is reduced for employers, and output is reduced for the wider economy. Productivity impacts to the economy also arise due to CVD-related mortality. Areas covered: A systematic literature review was conducted to identify and collate studies that report the magnitude of work-related productivity losses associated with CVD generally or specific cardiovascular (CV) events or conditions (coronary heart disease, MI, stroke, transient ischemic attack, angina, heart failure, peripheral artery disease, coronary revascularization). The search was conducted using Medline, Embase, the Cochrane Library, and Google to find studies published from January 2004 to January 2015. In total, 60 studies were identified, including 20 studies conducted in the USA, 25 studies conducted in Europe, and 18 studies conducted in other countries (three studies were conducted in multiple regions). The studies differed by the scope of losses assessed (absenteeism, presenteeism, early retirement, premature mortality) and CVD conditions/events included. Studies reported either average patient or population losses, and generally used a human capital rather than friction cost method. Outcomes were standardized and adjusted to 2015 US dollars where possible. Expert commentary: The review demonstrates that CVD imposes substantial morbidity- and mortality-related productivity costs. The studies identified in the review may be used to inform and populate societal economic evaluations in CVD, with the most appropriate source study being that most closely matching the context of the evaluation.
a Covance Market Access Services Inc. , Sydney , Australia.
Adam L
AL
Gordois
b University of Illinois College of Medicine , Peoria , IL , USA.|c Ciccarone Center for the Prevention of Cardiovascular Disease , Johns Hopkins University School of Medicine , Baltimore , MD , USA.
Peter P
PP
Toth
d Amgen, Inc. , Thousand Oaks , CA , USA.
Ruben Gw
RG
Quek
a Covance Market Access Services Inc. , Sydney , Australia.
Emma M
EM
Proudfoot
d Amgen, Inc. , Thousand Oaks , CA , USA.
Carly J
CJ
Paoli
d Amgen, Inc. , Thousand Oaks , CA , USA.
Shravanthi R
SR
Gandra
D000041:Absenteeism; D002318:Cardiovascular Diseases / Q000191:economics / Q000401:mortality / Q000503:physiopathology*; D004526:Efficiency; D006801:Humans; D009203:Myocardial Infarction / Q000191:economics / Q000401:mortality / Q000503:physiopathology; D020521:Stroke / Q000191:economics / Q000401:mortality / Q000503:physiopathology; D013997:Time Factors
Absenteeism; cardiovascular; cost; presenteeism; productivity; review; systematic